1,10-Phenanthroline reversibility inhibits proliferation of two human prostate carcinoma cell lines (PC-3 and DU145)
- 1 October 1984
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 124 (2) , 538-543
- https://doi.org/10.1016/0006-291x(84)91587-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Characterization of prostate-tissue-directed monoclonal antibody, ?-Pro 13Cancer Immunology, Immunotherapy, 1984
- Monoclonal antibodies to different epitopes on a prostate tumor-associated antigenCancer Immunology, Immunotherapy, 1983
- Control of the Balb/c‐3T3 cell cycle by nutrients and serum factors: Analysis using platelet‐derived growth factor and platelet‐poor plasmaJournal of Cellular Physiology, 1979
- Zinc and the steroid endocrinology of the human prostateThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Isolation of a human prostate carcinoma cell line (DU 145)International Journal of Cancer, 1978
- METAL–ANDROGEN INTERRELATIONSHIPS IN CARCINOMA AND HYPERPLASIA OF THE HUMAN PROSTATEJournal of Endocrinology, 1976
- Carcinoma of the Prostate: A Study of 213 Patients with Stage C Tumors Treated by Total Perineal ProstatectomyJournal of Urology, 1975
- Carcinoma of the Prostate and Lymphatic MetastasesJournal of Urology, 1974
- DNA synthesis by cultured lymphocytes: A modified method for measuring 3H-thymidine incorporationCellular Immunology, 1973
- Carcinoma of the Prostate Gland in Patients More Than 80 Years OldAmerican Journal of Clinical Pathology, 1964